-
1
-
-
84869395353
-
Should we standardize the 1, 700-year-old fecal microbiota transplantation?
-
Zhang F, Luo W, Shi Y, et al. Should we standardize the 1, 700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1755-6.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1755-1756
-
-
Zhang, F.1
Luo, W.2
Shi, Y.3
-
2
-
-
0001412472
-
Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis
-
Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-9.
-
(1958)
Surgery
, vol.44
, pp. 854-859
-
-
Eiseman, B.1
Silen, W.2
Bascom, G.S.3
-
3
-
-
84945942021
-
Fecal microbiota transplantation: Current clinical efficacy and future prospects
-
Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol 2015; 8: 285-91.
-
(2015)
Clin Exp Gastroenterol
, vol.8
, pp. 285-291
-
-
Bowman, K.A.1
Broussard, E.K.2
Surawicz, C.M.3
-
4
-
-
80054736926
-
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection
-
Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
-
(2011)
Clin Infect Dis
, vol.53
, pp. 994-1002
-
-
Gough, E.1
Shaikh, H.2
Manges, A.R.3
-
5
-
-
84873019302
-
Duodenal infusion of donor feces for recurrent Clostridium difficile
-
Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-15.
-
(2013)
N Engl J Med
, vol.368
, pp. 407-415
-
-
Van Nood, E.1
Vrieze, A.2
Nieuwdorp, M.3
-
6
-
-
84916933903
-
The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection
-
Singh R, Nieuwdorp M, ten Berge IJ, et al. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin Microbiol Infect 2014; 20: 1119-25.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 1119-1125
-
-
Singh, R.1
Nieuwdorp, M.2
Ten Berge, I.J.3
-
7
-
-
84916937261
-
Faecal microbiota transplantation: From practice to legislation before considering industrialization
-
Lagier JC. Faecal microbiota transplantation: from practice to legislation before considering industrialization. Clin Microbiol Infect 2014; 20: 1112-8.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 1112-1118
-
-
Lagier, J.C.1
-
8
-
-
84887259304
-
European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection
-
Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20 (suppl 2): 1-26.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 1-26
-
-
Debast, S.B.1
Bauer, M.P.2
Kuijper, E.J.3
-
9
-
-
84903894091
-
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients
-
Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109: 1065-71.
-
(2014)
Am J Gastroenterol
, vol.109
, pp. 1065-1071
-
-
Kelly, C.R.1
Ihunnah, C.2
Fischer, M.3
-
10
-
-
84937978296
-
Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: A preliminary report
-
Lagier JC, Delord M, Million M, et al. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report. Eur J Clin Microbiol Infect Dis 2015; 34: 1597-601.
-
(2015)
Eur J Clin Microbiol Infect Dis
, vol.34
, pp. 1597-1601
-
-
Lagier, J.C.1
Delord, M.2
Million, M.3
-
11
-
-
84887580913
-
Clostridium difficile 027 emerging outbreak in Marseille, France
-
Lagier JC, Dubourg G, Cassir N, et al. Clostridium difficile 027 emerging outbreak in Marseille, France. Infect Control Hosp Epidemiol 2013; 34: 1339-41.
-
(2013)
Infect Control Hosp Epidemiol
, vol.34
, pp. 1339-1341
-
-
Lagier, J.C.1
Dubourg, G.2
Cassir, N.3
-
12
-
-
84937251963
-
Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections
-
Million M, Hocquart M, Seghboyan JM, et al. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections. Int J Antimicrob Agents 2015; 46: 227-8.
-
(2015)
Int J Antimicrob Agents
, vol.46
, pp. 227-228
-
-
Million, M.1
Hocquart, M.2
Seghboyan, J.M.3
-
13
-
-
84963679952
-
Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection: A multicenter experience
-
Aroniadis OC, Brandt LJ, Greenberg A, et al. Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection: A multicenter experience. J Clin Gastroenterol 2016; 50: 398-402.
-
(2016)
J Clin Gastroenterol
, vol.50
, pp. 398-402
-
-
Aroniadis, O.C.1
Brandt, L.J.2
Greenberg, A.3
-
14
-
-
84930517281
-
Deadly infectious diseases such as Ebola: The parachute paradigm
-
Lagier JC, Raoult D. Deadly infectious diseases such as Ebola: the parachute paradigm. Clin Microbiol Infect 2015; 21: 389-90.
-
(2015)
Clin Microbiol Infect
, vol.21
, pp. 389-390
-
-
Lagier, J.C.1
Raoult, D.2
-
16
-
-
84917741051
-
Donor feces infusion for eradication of extended spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease
-
Singh R, van NE, Nieuwdorp M, et al. Donor feces infusion for eradication of extended spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect 2014; 20: 977-8.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 977-978
-
-
Singh, R.1
Van, N.E.2
Nieuwdorp, M.3
-
17
-
-
84929293479
-
Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae
-
Lagier JC, Million M, Fournier PE, et al. Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae. J Hosp Infect 2015; 90: 173-4.
-
(2015)
J Hosp Infect
, vol.90
, pp. 173-174
-
-
Lagier, J.C.1
Million, M.2
Fournier, P.E.3
-
18
-
-
84978327773
-
Loss of vancomycin-resistant enterococcus fecal dominance in an organ transplant patient with clostridium difficile colitis after fecal microbiota transplant
-
Stripling J, Kumar R, Baddley JW, et al. Loss of vancomycin-resistant enterococcus fecal dominance in an organ transplant patient with clostridium difficile colitis after fecal microbiota transplant. Open Forum Infect Dis 2015; 2: ofv078.
-
(2015)
Open Forum Infect Dis
, vol.2
, pp. ofv078
-
-
Stripling, J.1
Kumar, R.2
Baddley, J.W.3
-
19
-
-
84936860288
-
Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
-
Wei Y, Gong J, Zhu W, et al. Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis. BMC Infect Dis 2015; 15: 265.
-
(2015)
BMC Infect Dis
, vol.15
, pp. 265
-
-
Wei, Y.1
Gong, J.2
Zhu, W.3
-
20
-
-
84900418033
-
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study
-
Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-22.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 1515-1522
-
-
Youngster, I.1
Sauk, J.2
Pindar, C.3
-
22
-
-
84908681868
-
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection
-
Youngster I, Russell GH, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 312: 1772-8.
-
(2014)
JAMA
, vol.312
, pp. 1772-1778
-
-
Youngster, I.1
Russell, G.H.2
Pindar, C.3
-
23
-
-
84954543513
-
Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: A randomized clinical trial
-
Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 2016; 315: 142-9.
-
(2016)
JAMA
, vol.315
, pp. 142-149
-
-
Lee, C.H.1
Steiner, T.2
Petrof, E.O.3
-
24
-
-
84954566539
-
Expanded evidence for frozen fecal microbiota transplantation for Clostridium difficile infection: A fresh take
-
Malani PN, Rao K. Expanded evidence for frozen fecal microbiota transplantation for Clostridium difficile infection: A fresh take. JAMA 2016; 315: 137-8.
-
(2016)
JAMA
, vol.315
, pp. 137-138
-
-
Malani, P.N.1
Rao, K.2
-
25
-
-
85014702145
-
Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: Results of the PUNCH CD study
-
Orenstein R, Dubberke E, Hardi R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study. Clin Infect Dis 2015; civ938.
-
(2015)
Clin Infect Dis
, pp. civ938
-
-
Orenstein, R.1
Dubberke, E.2
Hardi, R.3
-
26
-
-
84958053761
-
Adverse events in faecal microbiota transplant: A review of the literature
-
Baxter M, Colville A. Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect 2016; 92: 117-27.
-
(2016)
J Hosp Infect
, vol.92
, pp. 117-127
-
-
Baxter, M.1
Colville, A.2
-
28
-
-
84978328160
-
Weight gain after fecal microbiota transplantation
-
Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2015; 2: ofv004.
-
(2015)
Open Forum Infect Dis
, vol.2
, pp. ofv004
-
-
Alang, N.1
Kelly, C.R.2
-
29
-
-
84953849261
-
Fatal aspiration pneumonia as a complication of fecal microbiota transplant
-
Baxter M, Ahmad T, Colville A, et al. Fatal aspiration pneumonia as a complication of fecal microbiota transplant. Clin Infect Dis 2015; 61: 136-7.
-
(2015)
Clin Infect Dis
, vol.61
, pp. 136-137
-
-
Baxter, M.1
Ahmad, T.2
Colville, A.3
-
30
-
-
84963935979
-
Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection
-
Costello SP, Tucker EC, La Brooy J, et al. Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clin Infect Dis 2016; 62: 908-14.
-
(2016)
Clin Infect Dis
, vol.62
, pp. 908-914
-
-
Costello, S.P.1
Tucker, E.C.2
La Brooy, J.3
-
31
-
-
84942104023
-
Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates
-
Cassir N, Benamar S, Khalil JB, et al. Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates. Clin Infect Dis 2015; 61: 1107-15.
-
(2015)
Clin Infect Dis
, vol.61
, pp. 1107-1115
-
-
Cassir, N.1
Benamar, S.2
Khalil, J.B.3
-
32
-
-
84960373289
-
Identification of an antiinflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease
-
Quevrain E, Maubert MA, Michon C, et al. Identification of an antiinflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65: 415-25.
-
(2016)
Gut
, vol.65
, pp. 415-425
-
-
Quevrain, E.1
Maubert, M.A.2
Michon, C.3
-
33
-
-
55949124035
-
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
-
Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-6.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 16731-16736
-
-
Sokol, H.1
Pigneur, B.2
Watterlot, L.3
-
34
-
-
84929148131
-
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. Difficile infection: A randomized clinical trial
-
Gerding DN, Meyer T, Lee C, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015; 313: 1719-27.
-
(2015)
JAMA
, vol.313
, pp. 1719-1727
-
-
Gerding, D.N.1
Meyer, T.2
Lee, C.3
-
35
-
-
84920943976
-
The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota
-
Lagier JC, Hugon P, Khelaifia S et al. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev 2015; 28: 237-64.
-
(2015)
Clin Microbiol Rev
, vol.28
, pp. 237-264
-
-
Lagier, J.C.1
Hugon, P.2
Khelaifia, S.3
-
36
-
-
84948461699
-
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
-
Vetizou M, Pitt JM, Daillere R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015; 350: 1079-84.
-
(2015)
Science
, vol.350
, pp. 1079-1084
-
-
Vetizou, M.1
Pitt, J.M.2
Daillere, R.3
-
37
-
-
85008352532
-
Culturomics: Une méthode d'étude du microbiote humain
-
Lagier JC, Raoult D. Culturomics: une méthode d'étude du microbiote humain. Med Sci (Paris) 2016; 32: 923-5.
-
(2016)
Med Sci (Paris)
, vol.32
, pp. 923-925
-
-
Lagier, J.C.1
Raoult, D.2
-
38
-
-
85008352198
-
Microbiote intestinal et réponses aux thérapies anti-tumorales
-
Vétizou M, Daillère R, Zitvogel L. Microbiote intestinal et réponses aux thérapies anti-tumorales. Med Sci (Paris) 2016; 32: 974-82
-
(2016)
Med Sci (Paris)
, vol.32
, pp. 974-982
-
-
Vétizou, M.1
Daillère, R.2
Zitvogel, L.3
|